Gastric cancer
Conditions
Interventions
Retrospective overall cohort:None
Prospective overall cohort:None
Sponsors
Southern Medical University Southern Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Retrospective cohort 1. Age >= 18 years (); 2. Pathologically or cytologically confirmed gastric cancer, eligible for radical resection, and histologically verified to be predominantly adenocarcinoma (retrospective cohort); 3. Gender: male or female (retrospective cohort); 4. Patients who visited Nanfang Hospital, Southern Medical University between January 2010 and November 2024; met the requirements for regular clinical follow-up of gastric cancer; had no contact with the hospital for at least one year after the follow-up time point; and received complete immunotherapy (including preoperative neoadjuvant immunotherapy) (retrospective cohort); 5. Received complete immunotherapy (including preoperative neoadjuvant immunotherapy) (retrospective cohort); prospective cohort 1. Voluntarily signed the informed consent form; 2. Age >= 18 years; 3. Pathologically or cytologically confirmed gastric cancer, eligible for radical resection, and histologically verified to be predominantly adenocarcinoma; 4. Gender: male or female; 5. Received complete immunotherapy (including preoperative neoadjuvant immunotherapy); 6. Agreed to the use of their own medical data for this research study.
Exclusion criteria
Exclusion criteria: 1.Judged by the researchers as ineligible for participation in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pathological Complete Response;Overall Survival;Major Pathological Response;Area Under the Curve;Progression-Free Survival; | — |
Countries
China
Contacts
Public ContactYanfeng Hu
Southern Medical University Southern Hospital
Outcome results
None listed